Seeing Is Believing
Healthcare - Sector
Clovis Oncology's activity chart (see below) currently has 163 price targets and 125 ratings on display.
Analysts average stock forecasts to be materialized ratio is 56.35% with an average time for these price targets to be met of 81.22 days.
Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 14-Jun-2022. First documented stock forecast 03-Jun-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Jun-2022
4 years 5 months ago
(14-Jun-2022)
0/13 (0%)
$2.53 (172.11%)
Hold Since 30-Oct-2018
$4.75
$4.66 (5177.78%)
$5.75
5 years 11 days ago
(03-Nov-2021)
12/14 (85.71%)
$0.06 (1.28%)
55
Sell Since 20-May-2020
$3
$2.91 (3233.33%)
6 years 8 days ago
(06-Nov-2020)
6/8 (75%)
$-1.26 (-29.58%)
123
Buy Since 22-Feb-2018
$16
$15.91 (17677.78%)
$17
6 years 3 months 7 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
88
Sell Since 08-Oct-2019
6 years 6 months 8 days ago
(06-May-2020)
0/2 (0%)
$25.85 (43.70%)
What is CLVS (Clovis Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on CLVS (Clovis Oncology)?
Which analyst has the most public recommendations on CLVS (Clovis Oncology)?
Which analyst is the currently most bullish on CLVS (Clovis Oncology)?
Which analyst is the currently most reserved on CLVS (Clovis Oncology)?